Home    Back

Zeaxanthin    (DrugBank: Zeaxanthin)

1 disease
IDDisease name (Link within this page)Number of trials
164Oculocutaneous albinism1

164. Oculocutaneous albinism    [ 15 clinical trials,   57 drugs,   (DrugBank: 34 drugs),   34 drug target genes,   136 drug target pathways]
Searched query = "Oculocutaneous albinism", "Hermansky-Pudlak syndrome", "Chediak-Higashi syndrome", "Griscelli syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 15 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02200263
(ClinicalTrials.gov)		November 201423/7/2014The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With AlbinismA Randomized Placebo-controlled Trial to Investigate the Effect of Lutein and Zeaxanthin Supplementation on Macular Pigment and Visual Function in Albinism - LUtein for VIsion in Albinism (LUVIA)Ocular Albinism (OA);Oculocutaneous Albinism (OCA)Dietary Supplement: Lutein plus Zeaxanthin;Dietary Supplement: PlaceboJohns Hopkins UniversityClark Charitable Foundation Inc.Completed12 YearsN/AAll10N/AUnited States